Company profile: Freespira
1.1 - Company Overview
Company description
- Provider of the only FDA-cleared, at-home, drug-free digital therapeutic proven to significantly reduce or eliminate panic attacks, panic disorder, and PTSD symptoms in 28 days. The Freespira treatment uses a sensor and tablet to normalize breathing. Also offers resources for health plans, employees, and individuals, a veterans relief program, and a provider referral program with insurance coverage information.
Products and services
- Resources for Health Plans: Evidence-based materials for health plans that supply clinical evidence and real-world results on Freespira’s effectiveness for reducing panic disorder and PTSD symptoms
- Freespira Treatment: The only FDA-cleared digital therapeutic delivering a 28-day, at-home, medication-free program using a sensor and tablet to normalize breathing and significantly reduce or eliminate panic attacks and PTSD symptoms
- Relief for Veterans: Clinical-study-supported program offering the Freespira system to veterans to treat panic and PTSD symptoms, with clinical studies demonstrating effectiveness
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Freespira
Vaxxinity
HQ: United States
Website
- Description: Provider of synthetic peptide vaccine technologies and Active Immunotherapy Medicines (AIMs) that stimulate antibody production to address chronic and infectious diseases, including UB-311 for mild Alzheimer’s (targets amyloid beta), UB-312 for Parkinson’s (targets alpha-synuclein), VXX-401 anti-PCSK9 to reduce LDL-C for heart disease, and UB-612, a multitope protein-peptide vaccine against SARS-CoV-2 variants like Omicron.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Vaxxinity company profile →
Taysha Gene Therapies
HQ: United States
Website
- Description: Provider of gene therapies targeting severe, life-threatening monogenic diseases of the central nervous system, including TSHA-102 for Rett syndrome. Services include conducting clinical trials to assess safety and efficacy, offering an expanded access program for investigational therapies, advancing gene therapy research, and providing patient affairs support and educational resources with advocacy partnerships.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Taysha Gene Therapies company profile →
Neural Therapeutics
HQ: Canada
Website
- Description: Provider of ethnobotanical drug discovery, psychedelic-based therapeutics for mental health, and dietary supplements. Focuses on San Pedro cactus for mescaline-derived compounds, conducts pharma and nutraceutical R&D leveraging indigenous knowledge, develops IP with partners like Validity Labs, and establishes sustainable, legally compliant sourcing and cultivation in Peru.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neural Therapeutics company profile →
SiteOne Therapeutics
HQ: United States
Website
- Description: Provider of novel non-opioid therapeutics and diagnostics for acute and chronic pain, including STC-004, an investigational NaV1.8-selective treatment; ST-2427, a highly selective NaV1.7 inhibitor for moderate-to-severe pain administered intravenously; and an inhaled NaV1.7-targeting therapy for chronic cough to reduce nerve fiber sensitivity.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SiteOne Therapeutics company profile →
Inbrain Neuroelectronics
HQ: Spain
Website
- Description: Provider of graphene-based brain-computer interface therapeutics and precision neurology solutions that combine high-resolution, skin-like BCI decoding with micrometric modulation in a closed loop to deliver adaptive, personalized treatments for Parkinson’s disease, epilepsy, and stroke. Offerings include implantable neural processors, an AI-powered therapy platform, and Innervia systems for vagus nerve modulation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inbrain Neuroelectronics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Freespira
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Freespira
2.2 - Growth funds investing in similar companies to Freespira
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Freespira
4.2 - Public trading comparable groups for Freespira
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →